HOUSE AMENDMENT Bill No. SB 1252
1	CHAMBER ACTION
2	Senate House
3	.
4	.
5	.
6
7
8
9
10
11
12	Representative Murman offered the following:
13
14	Amendment (with directory and title amendments)
15	On page 29, lines 14-18,
16	remove: all of said lines
17
18	and insert:
19	Administration to implement section 13 of this act during the
20	2002-2003 fiscal year. This section takes effect May 1, 2003.
21	Section 15. Section 430.83, Florida Statutes, is created
22	to read:
23	430.83 Sunshine for Seniors Program.--
24	(1) POPULAR NAME.--This section shall be known by the
25	popular name "The Sunshine for Seniors Act."
26	(2) DEFINITIONS.--As used in this section, the term:
27	(a) "Application assistance organization" means any
28	private organization that assists individuals with obtaining
29	prescription drugs through manufacturers’ pharmaceutical
30	assistance programs.
31	(b) "Eligible individual" means any individual who is 60
32	years of age or older who lacks adequate pharmaceutical
33	insurance coverage.
34	(c) "Manufacturers’ pharmaceutical assistance program"
35	means any program offered by a pharmaceutical manufacturer that
36	provides low-income individuals with prescription drugs free or
37	at reduced prices, including, but not limited to, senior
38	discount card programs and patient assistance programs.
39	(3) LEGISLATIVE FINDINGS AND INTENT.--The Legislature
40	finds that the pharmaceutical manufacturers, seeing a need, have
41	created charitable programs to aid low-income seniors with the
42	cost of prescription drugs. The Legislature also finds that many
43	low-income seniors are unaware of such programs or either do not
44	know how to apply for or need assistance in completing the
45	applications for such programs. Therefore, it is the intent of
46	the Legislature that the Department of Elderly Affairs, in
47	consultation with the Agency for Health Care Administration,
48	implement and oversee the Sunshine for Seniors Program to help
49	seniors in accessing manufacturers’ pharmaceutical assistance
50	programs.
51	(4) SUNSHINE FOR SENIORS PROGRAM.--There is established a
52	program to assist low-income seniors with obtaining prescription
53	drugs from manufacturers’ pharmaceutical assistance programs,
54	which shall be known as the "Sunshine for Seniors Program."
55	Implementation of the program is subject to the availability of
56	funding and any limitations or directions provided for by the
57	General Appropriations Act or chapter 216.
58	(5) IMPLEMENTATION AND OVERSIGHT DUTIES.--In implementing
59	and overseeing the Sunshine for Seniors Program, the Department
60	of Elderly Affairs:
61	(a) Shall promote the availability of manufacturers’
62	pharmaceutical assistance programs to eligible individuals with
63	various outreach initiatives.
64	(b) Shall, working cooperatively with pharmaceutical
65	manufacturers and consumer advocates, develop a uniform
66	application form, which shall be available in English, Spanish,
67	and Creole, to be completed by seniors who wish to participate
68	in the Sunshine for Seniors Program.
69	(c) May request proposals from application assistance
70	organizations to assist eligible individuals with obtaining
71	prescription drugs through manufacturers’ pharmaceutical
72	assistance programs.
73	(d) Shall train volunteers to help eligible individuals
74	fill out applications for the manufacturers’ pharmaceutical
75	assistance programs.
76	(e) Shall train volunteers to determine if applicants are
77	available for other state programs.
78	(f) Shall seek federal funds to help fund the Sunshine for
79	Seniors Program.
80	(g) May seek federal waivers to help fund the Sunshine for
81	Seniors Program.
82	(6) COMMUNITY PARTNERSHIPS.--The Department of Elderly
83	Affairs may build private-sector and public-sector partnerships
84	with corporations, hospitals, physicians, pharmacists,
85	foundations, volunteers, state agencies, community groups, area
86	agencies on aging, and any other entities that will further the
87	intent of this section. These community partnerships may also be
88	used to facilitate other pro bono benefits for eligible
89	individuals, including, but not limited to, medical, dental, and
90	prescription services.
91	(7) CONTRACTS.--The Department of Elderly Affairs may
92	select and contract with application assistance organizations to
93	assist eligible individuals in obtaining their prescription
94	drugs through the manufacturers’ pharmaceutical assistance
95	programs. If the department contracts with an application
96	assistance organization, the department shall evaluate quarterly
97	the performance of the application assistance organization to
98	ensure compliance with the contract and the quality of service
99	provided to eligible individuals.
100	(8) REPORTS AND EVALUATIONS.--By January 1 of each year,
101	while the Sunshine for Seniors Program is operating, the
102	Department of Elderly Affairs shall report to the Legislature
103	regarding the implementation and operation of the Sunshine for
104	Seniors Program.
105	(9) NONENTITLEMENT.--The Sunshine for Seniors Program
106	established by this section is not an entitlement. If funds are
107	insufficient to assist all eligible individuals, the Department
108	of Elderly Affairs may develop a waiting list prioritized by
109	application date.
110	Section 16. Section 409.9065, Florida Statutes, is amended
111	to read:
112	409.9065 Pharmaceutical expense assistance.--
113	(1) PROGRAM ESTABLISHED.--There is established a program
114	to provide pharmaceutical expense assistance to eligiblecertain
115	low-income elderly individuals, which shall be known as the "Ron
116	Silver Senior Drug Program" and may be referred to as the
117	"Silver Lifesaver Program."
118	(2) ELIGIBILITY.--Eligibility for the program is limited
119	to those individuals who qualify for limited assistance under
120	the Florida Medicaid program as a result of being dually
121	eligible for both Medicare and Medicaid, but whose limited
122	assistance or Medicare coverage does not include any pharmacy
123	benefit. To the extent funds are appropriated, specifically
124	eligible individuals are individuals who:
125	(a) Are Florida residents age 65 and over;
126	(b) Have an income equal to or less than 200 percent of
127	the federal poverty level;:
128	1. Between 88 and 120 percent of the federal poverty
129	level;
130	2. Between 88 and 150 percent of the federal poverty level
131	if the Federal Government increases the federal Medicaid match
132	for persons between 100 and 150 percent of the federal poverty
133	level; or
134	3. Between 88 percent of the federal poverty level and a
135	level that can be supported with funds provided in the General
136	Appropriations Act for the program offered under this section
137	along with federal matching funds approved by the Federal
138	Government under a s. 1115 waiver. The agency is authorized to
139	submit and implement a federal waiver pursuant to this
140	subparagraph. The agency shall design a pharmacy benefit that
141	includes annual per-member benefit limits and cost-sharing
142	provisions and limits enrollment to available appropriations and
143	matching federal funds. Prior to implementing this program, the
144	agency must submit a budget amendment pursuant to chapter 216;
145	(c) Are eligible for both Medicare and Medicaid;
146	(d) Have exhausted pharmacy benefits under Medicare,
147	Medicaid, or any other insurance planAre not enrolled in a
148	Medicare health maintenance organization that provides a
149	pharmacy benefit; and
150	(e) Request to be enrolled in the program.
151	(3) BENEFITS.--Eligible individuals shall receive a
152	discount for prescription drugsMedications covered under the
153	pharmaceutical expense assistance program are those covered
154	under the Medicaid program in s. 409.906(20)(19). Monthly
155	benefit payments shall be limited to $80 per program
156	participant. Participants are required to make a 10-percent
157	coinsurance payment for each prescription purchased through this
158	program.
159	(a) Eligible individuals with incomes equal to or less
160	than 120 percent of the federal poverty level shall receive a
161	discount of 100 percent for the first $160 worth of prescription
162	drugs they receive each month, subject to copayments that the
163	agency requires on these benefits. For all other prescription
164	drugs received each month, eligible individuals shall receive a
165	discount of 50 percent.
166	(b) Eligible individuals with incomes of more than 120
167	percent but not more than 150 percent of the federal poverty
168	level shall receive a discount of 50 percent.
169	(c) Eligible individuals with incomes of more than 150
170	percent but not more than 175 percent of the federal poverty
171	level shall receive a discount of 41 percent.
172	(d) Eligible individuals with incomes of more than 175
173	percent but not more than 200 percent of the federal poverty
174	level shall receive a discount of 37 percent.
175	(4) ADMINISTRATION.--The pharmaceutical expense assistance
176	program shall be administered by the agency for Health Care
177	Administration, in collaborationconsultationwith the
178	Department of Elderly Affairs and the Department of Children and
179	Family Services.
180	(a) The Agency for Health Care Administration and the
181	Department of Elderly Affairs shall develop a single-page
182	application for the pharmaceutical expense assistance program.
183	(a)(b) The agency for Health Care Administrationshall, by
184	rule, establish for the pharmaceutical expense assistance
185	program eligibility requirements;, limits on participation;,
186	benefit limitations, including copayments;a requirement for
187	generic drug substitution;,and other program parameters
188	comparable to those of the Medicaid program. However, there
189	shall be no monetary limit on prescription drugs purchased with
190	discounts of less than 51 percent unless the agency determines
191	there is a risk of a funding shortfall in the program. If the
192	agency determines there is a risk of a funding shortfall, the
193	agency may establish monetary limits on prescription drugs which
194	shall not be less than $160 worth of prescription drugs per
195	month.
196	(b)(c) By January 1 of each year, the agency for Health
197	Care Administrationshall report to the Legislature on the
198	operation of the program. The report shall include information
199	on the number of individuals served, use rates, and expenditures
200	under the program. The report shall also address the impact of
201	the program on reducing unmet pharmaceutical drug needs among
202	the elderly and recommend programmatic changes.
203	(5) NONENTITLEMENT.--The pharmaceutical expense assistance
204	program established by this section is not an entitlement.
205	Enrollment levels are limited to those authorized by the
206	Legislature in the annual General Appropriations Act. If, after
207	establishing monetary limits as required by paragraph (4)(a),
208	funds are insufficient to serve all eligible individuals
209	eligible under subsection (2) andseeking coverage, the agency
210	may develop a waiting list based on application dates to use in
211	enrolling individuals in unfilled enrollment slots.
212	(6) PHARMACEUTICAL MANUFACTURER PARTICIPATION.--In order
213	for a drug product to be covered under Medicaid or this program,
214	the product's manufacturer shall:
215	(a) Provide a rebate to the state equal to the rebate
216	required by the Medicaid program; and
217	(b) Make the drug product available to the program for the
218	best price that the manufacturer makes the drug product
219	available in the Medicaid program.
220	(7) REIMBURSEMENT.--Totalreimbursements to pharmacies
221	participating in the pharmaceutical expense assistance program
222	established under this section shall be equivalent to
223	reimbursements under the Medicaid program.
224	(8) FEDERAL APPROVAL.--The benefits provided in this
225	section are limited to those approved by the Federal Government
226	pursuant to a Medicaid waiver or an amendment to the state
227	Medicaid plan.
228	Section 17. Subsections (7), (8), and (9) are added to
229	section 430.502, Florida Statutes, to read:
230	430.502 Alzheimer's disease; memory disorder clinics and
231	day care and respite care programs.--
232	(7) The Agency for Health Care Administration and the
233	department shall seek a federal waiver to implement a Medicaid
234	home and community-based waiver targeted to persons with
235	Alzheimer's disease to test the effectiveness of Alzheimer’s
236	specific interventions to delay or to avoid institutional
237	placement.
238	(8) The department will implement the waiver program
239	specified in subsection (7). The agency and the department shall
240	ensure that providers are selected that have a history of
241	successfully serving persons with Alzheimer's disease. The
242	department and the agency shall develop specialized standards
243	for providers and services tailored to persons in the early,
244	middle, and late stages of Alzheimer's disease and designate a
245	level of care determination process and standard that is most
246	appropriate to this population. The department and the agency
247	shall include in the waiver services designed to assist the
248	caregiver in continuing to provide in-home care. The department
249	shall implement this waiver program subject to a specific
250	appropriation or as provided in the General Appropriations Act.
251	The department and the agency shall submit their program design
252	to the President of the Senate and the Speaker of the House of
253	Representatives for consultation during the development process.
254	(9) Authority to continue the waiver program specified in
255	subsection (7) shall be automatically eliminated at the close of
256	the 2008 Regular Session of the Legislature unless further
257	legislative action is taken to continue it prior to such time.
258	Section 18. Paragraph (t) is added to subsection (3) of
259	section 408.036, Florida Statutes, to read:
260	408.036 Projects subject to review.--
261	(3) EXEMPTIONS.--Upon request, the following projects are
262	subject to exemption from the provisions of subsection (1):
263	(t)1. For the provision of adult open-heart services in a
264	hospital located within the boundaries of Palm Beach, Polk,
265	Martin, St. Lucie, and Indian River Counties if the following
266	conditions are met: The exemption must be based upon objective
267	criteria and address and solve the twin problems of geographic
268	and temporal access. A hospital shall be exempt from the
269	certificate-of-need review for the establishment of an open-
270	heart-surgery program when the application for exemption
271	submitted under this paragraph complies with the following
272	criteria:
273	a. The applicant must certify that it will meet and
274	continuously maintain the minimum licensure requirements adopted
275	by the agency governing adult open-heart programs, including the
276	most current guidelines of the American College of Cardiology
277	and American Heart Association Guidelines for Adult Open Heart
278	Programs.
279	b. The applicant must certify that it will maintain
280	sufficient appropriate equipment and health personnel to ensure
281	quality and safety.
282	c. The applicant must certify that it will maintain
283	appropriate times of operation and protocols to ensure
284	availability and appropriate referrals in the event of
285	emergencies.
286	d. The applicant can demonstrate that it is referring 300
287	or more patients per year from the hospital, including the
288	emergency room, for cardiac services at a hospital with cardiac
289	services, or that the average wait for transfer for 50 percent
290	or more of the cardiac patients exceeds 4 hours.
291	e. The applicant is a general acute care hospital that is
292	in operation for 3 years or more.
293	f. The applicant is performing more than 300 diagnostic
294	cardiac catheterization procedures per year, combined inpatient
295	and outpatient.
296	g. The applicant's payor mix at a minimum reflects the
297	community average for Medicaid, charity care, and self-pay
298	patients or the applicant must certify that it will provide a
299	minimum of 5 percent of Medicaid, charity care, and self-pay to
300	open-heart-surgery patients.
301	h. If the applicant fails to meet the established criteria
302	for open-heart programs or fails to reach 300 surgeries per year
303	by the end of its third year of operation, it must show cause
304	why its exemption should not be revoked.
305	2. By December 31, 2004, and annually thereafter, the
306	Agency for Health Care Administration shall submit a report to
307	the Legislature providing information concerning the number of
308	requests for exemption received under this paragraph and the
309	number of exemptions granted or denied.
310	Section 19. There is annually appropriated the recurring
311	sum of $10 million from the General Revenue Fund to the Florida
312	Alzheimer’s Center and Research Institute as established in s.
313	1004.445, Florida Statutes, to be used for research relating to
314	the prevention, treatment, and cure of Alzheimer’s disease.
315	Section 20. The sum of $20 million is appropriated from
316	the Public Education Capital Outlay and Debt Service Trust Fund
317	for the construction of the Florida Alzheimer's Center and
318	Research Institute at the University of South Florida. The
319	Florida Alzheimer’s Center and Research Institute shall direct
320	the Board of Trustees of the University of South Florida on the
321	expenditure of these funds.
322	Section 21. James and Esther King Center for Universal
323	Research to Eradicate Disease.--
324	(1) The Legislature finds that an estimated 128 million
325	Americans suffer from acute, chronic, and degenerative diseases
326	and that biomedical research is the key to finding cures for
327	these diseases that negatively affect all Floridians. The
328	Legislature further finds that, while there is much research
329	being conducted throughout this state and throughout the world,
330	there is a lack of coordination of efforts among researchers.
331	The Legislature, therefore, finds that there is a significant
332	need for a coordinated effort if the goal of curing disease is
333	to be achieved. Moreover, the Legislature finds that the
334	biomedical technology sector meets the criteria of a high-impact
335	sector, pursuant to section 288.108, Florida Statutes, having a
336	high importance to this state's economy with a significant
337	potential for growth and contribution to our universities and
338	quality of life.
339	(2) It is the intent of the Legislature that Florida
340	strive to become the nation's leader in biomedical research and
341	commit itself to being the state to find cures for the most
342	deadly and widespread diseases. It is further the intent of the
343	Legislature that there be a coordinated effort among the state's
344	public and private universities and the biomedical industry to
345	discover such cures. Moreover, it is the intent of the
346	Legislature to expand the state economy by attracting biomedical
347	researchers and research companies to this state.
348	(3) There is established the James and Esther King Center
349	for Universal Research to Eradicate Disease, which shall be
350	known as the "CURED."
351	(a) The purpose of the center is to coordinate, improve,
352	expand, and monitor all biomedical research programs within the
353	state, facilitate funding opportunities, and foster improved
354	technology transfer of research findings into clinical trials
355	and widespread public use.
356	(b) The goal of the center is to find cures for diseases
357	such as cancer, heart disease, lung disease, diabetes, and
358	neurological disorders, including Alzheimer's disease, epilepsy,
359	and Parkinson's disease.
360	(c) The center shall hold an annual biomedical technology
361	summit in Florida to which biomedical researchers, biomedical
362	technology companies, business incubators, pharmaceutical
363	manufacturers, and others around the nation and world are
364	invited to share biomedical research findings in order to
365	expedite the discovery of cures. Summit attendees will be
366	required to cover the costs of such attendance or obtain
367	sponsorship for such attendance.
368	(d) The center shall encourage clinical trials in this
369	state on research that holds promise of curing a disease or
370	condition. The center shall facilitate partnerships between
371	researchers, treating physicians, and community hospitals for
372	the purpose of sharing new techniques and new research findings,
373	as well as coordinating voluntary donations to ensure an
374	adequate supply of adult stem cells or cord blood.
375	(e) The center shall also encourage the discovery and
376	production in Florida of vaccines that prevent disease.
377	(f) The center shall monitor the supply and demand needs
378	of researchers relating to stem cell research and other types of
379	human tissue research. If the center determines that there is a
380	need for increased donation of human tissue, it shall notify
381	hospitals licensed pursuant to chapter 395, Florida Statutes,
382	that have entered into partnership agreements with research
383	institutes conducting stem cell research located in the same
384	geographic region as the researchers demanding the stem cells or
385	other tissues. Such hospitals shall then implement programs that
386	encourage voluntary donations of cord blood or other needed
387	adult tissue.
388	(g) The center shall be funded through private, state, and
389	federal sources.
390	(h) The center shall serve as a registry of all known
391	biomedical grant opportunities and may assist any public or
392	private biomedical research program in this state in preparing
393	grant requests.
394	(i) The center shall maintain a website with links to
395	peer-reviewed biomedical research. The website shall also
396	contain a list of all known biomedical research being conducted
397	in Florida and shall facilitate communication among researchers
398	and other interested parties.
399	(j) The center shall submit an annual report to the
400	Governor, the President of the Senate, and the Speaker of the
401	House of Representatives no later than January 15 which contains
402	recommendations for legislative change necessary to foster a
403	positive climate for biomedical research in this state.
404	(k) The duties of the center may be outsourced to a
405	private entity or state university.
406	(4) There is established within the center an advisory
407	council which shall meet at least annually.
408	(a) The council shall consist of the members of the board
409	of directors of the Florida Research Consortium and at least one
410	representative from:
411	1. The Emerging Technology Commission.
412	2. Enterprise Florida, Inc.
413	3. BioFlorida.
414	4. The Florida Biomedical Research Advisory Council.
415	5. The Florida Medical Foundation.
416	6. Pharmaceutical Research and Manufacturers of America.
417	(b) Members of the council shall serve without
418	compensation and each organization represented shall cover all
419	expenses of its representative.
420	Section 22. Paragraphs (a) and (b) of subsection (1),
421	subsection (2), and paragraph (f) of subsection (10) of section
422	215.5602, Florida Statutes, are amended to read:
423	215.5602 Florida Biomedical Research Program.--
424	(1) There is established within the Department of Health
425	the Florida Biomedical Research Program funded by the proceeds
426	of the Lawton Chiles Endowment Fund pursuant to s. 215.5601. The
427	purpose of the Florida Biomedical Research Program is to provide
428	an annual and perpetual source of funding in order to support
429	research initiatives that address the health care problems of
430	Floridians in the areas of tobacco-related cancer,
431	cardiovascular disease, stroke, and pulmonary disease. The long-
432	term goals of the program are to:
433	(a) Improve the health of Floridians by researching better
434	prevention, diagnoses, and treatments, and curesfor cancer,
435	cardiovascular disease, stroke, and pulmonary disease.
436	(b) Expand the foundation of biomedical knowledge relating
437	to the prevention, diagnosis, and treatment, and cureof
438	diseases related to tobacco use, including cancer,
439	cardiovascular disease, stroke, and pulmonary disease.
440	(2) Funds appropriated for the Florida Biomedical Research
441	Program shall be used exclusively for the award of grants and
442	fellowships as established in this section; for research
443	relating to the prevention, diagnosis, and treatment, and cure
444	of diseases related to tobacco use, including cancer,
445	cardiovascular disease, stroke, and pulmonary disease; and for
446	expenses incurred in the administration of this section.
447	Priority shall be granted to research designed to prevent or
448	cure disease.
449	(10) The council shall submit an annual progress report on
450	the state of biomedical research in this state to the Governor,
451	the Secretary of Health, the President of the Senate, and the
452	Speaker of the House of Representatives by February 1. The
453	report must include:
454	(f) Progress in the prevention, diagnosis, and treatment,
455	and cureof diseases related to tobacco use, including cancer,
456	cardiovascular disease, stroke, and pulmonary disease.
457	Section 23. Florida Cancer Research Cooperative.--
458	(1) Effective July 1, 2003, the Florida Cancer Research
459	Cooperative is established for the purpose of making the State
460	of Florida a world class center for cancer research.
461	(2)(a) A not-for-profit corporation, acting as an
462	instrumentality of the Florida Dialogue on Cancer, shall be
463	organized for the purpose of governing the affairs of the
464	cooperative.
465	(b) The Florida Cancer Research Cooperative, Inc., may
466	create not-for-profit corporate subsidiaries to fulfill its
467	mission. The not-for-profit corporation and its subsidiaries are
468	authorized to receive, hold, invest, and administer property and
469	any moneys acquired from private, local, state, and federal
470	sources, as well as technical and professional income generated
471	or derived from the mission-related activities of the
472	cooperative.
473	(c) The affairs of the not-for-profit corporation shall be
474	managed by a board of directors which shall consist of:
475	1. The Secretary of the Department of Health or his or her
476	designee;
477	2. The Chief Executive Officer of the H. Lee Moffitt
478	Cancer Center or his or her designee;
479	3. The President of the University of Florida Shands
480	Cancer Center or his or her designee;
481	4. The Chief Executive Officer of the University of Miami
482	Sylvester Comprehensive Cancer Center or his or her designee;
483	5. The Chief Executive Officer of the Mayo Clinic,
484	Jacksonville or his or her designee;
485	6. The Chief Executive Officer of the American Cancer
486	Society, Florida Division or his or her designee;
487	7. The President of the American Cancer Society, Florida
488	Division Board of Directors or his or her designee;
489	8. The President of the Florida Society of Clinical
490	Oncology or his or her designee;
491	9. The Chief Executive Officer of Enterprise Florida,
492	Inc., or his or her designee;
493	10. Three representatives from large Florida hospitals or
494	institutions, not delineated in subparagraphs 1. through 6.,
495	that treat a large volume of cancer patients. One shall be
496	appointed by the Governor, one shall be appointed by the Speaker
497	of the House of Representatives, and one shall be appointed by
498	the President of the Senate;
499	11. Three representatives from community-based, statewide
500	organizations serving populations that experience cancer
501	disparities, one of whom shall be appointed by the Governor, one
502	of whom shall be appointed by the Speaker of the House of
503	Representatives, and one of whom shall be appointed by the
504	President of the Senate;
505	12. One member of the Florida House of Representatives, to
506	be appointed by the Speaker of the House of Representatives;
507	13. One member of the Florida Senate, to be appointed by
508	the President of the Senate;
509	14. Three university presidents, one of whom shall be
510	appointed by the Governor, one of whom shall be appointed by the
511	Speaker of the House of Representatives, and one of whom shall
512	be appointed by the President of the Senate; and
513	15. Five representatives from other statewide public
514	health organizations whose missions include public education and
515	the eradication of cancer, three of whom shall be appointed by
516	the Governor, one of whom shall be appointed by the Speaker of
517	the House of Representatives, and one of whom shall be appointed
518	by the President of the Senate.
519	(d) Appointments made by the Speaker of the House of
520	Representatives and the President of the Senate pursuant to
521	paragraph (c) shall be for 2-year terms, concurrent with the
522	bienniums in which they serve as presiding officers.
523	(e) Appointments made by the Governor pursuant to
524	paragraph (c) shall be for 2-year terms, although the Governor
525	may reappoint directors.
526	(f) Members of the board of directors of the not-for-
527	profit corporation or any subsidiaries shall serve without
528	compensation.
529	(3) The cooperative shall issue an annual report to the
530	Governor, the Speaker of the House of Representatives, and the
531	President of the Senate, by December 15 of each year, with
532	policy and funding recommendations regarding cancer research
533	capacity in Florida and related issues.
534	Section 24. Florida Cancer Research Cooperative; mission
535	and duties.--
536	(1) The cooperative shall develop and centralize the
537	processes and shared services for expanding cancer research in
538	Florida through:
539	(a) Support through bioinformatics, in order to create a
540	cancer informatics infrastructure that enhances information and
541	resource exchange and integration through researchers working in
542	diverse disciplines to facilitate the full spectrum of cancer
543	investigations;
544	(b) Technical coordination, business development, and
545	support of intellectual property;
546	(c) Development of a statewide cancer clinical trials
547	network as contemplated in section 21 of this act; and
548	(d) Other multidisciplinary research support activities.
549	(2) The cooperative shall work in concert with the Center
550	for Universal Research to Eradicate Disease created in section
551	21 of this act to ensure that the goals of the center are
552	advanced.
553	Section 25. There is annually appropriated the recurring
554	sum of $15 million from the General Revenue Fund to the James
555	and Esther King Center for Universal Research to Eradicate
556	Disease to be used for the purposes established in section 21 of
557	this act or similar legislation enacted into law at the 2003
558	Regular Session.
559	Section 26. Section 1004.383, Florida Statutes, is created
560	to read:
561	1004.383 Chiropractic medicine degree program at Florida
562	State University.--A chiropractic medicine degree program is
563	authorized at Florida State University.
564	Section 27. Section 460.4062, Florida Statutes, is created
565	to read:
566	460.4062 Chiropractic medicine faculty certificate.--
567	(1) The Department of Health may issue a chiropractic
568	medicine faculty certificate without examination to an
569	individual who remits a nonrefundable application fee, not to
570	exceed $100 as determined by rule of the Board of Chiropractic
571	Medicine, and who demonstrates to the Board of Chiropractic
572	Medicine that he or she meets the following requirements:
573	(a) Is a graduate of an accredited school or college of
574	chiropractic medicine accredited by the Council on Chiropractic
575	Education.
576	(b) Holds a valid current license to practice chiropractic
577	medicine in another jurisdiction in the United States.
578	(c) Is at least 21 years of age and of good moral
579	character.
580	(d) Has not committed any act or offense in any
581	jurisdiction which would constitute the basis for discipline
582	under chapter 456 or chapter 460.
583	(e) Has been offered and has accepted a full-time faculty
584	appointment to teach in a program of chiropractic medicine at a
585	state university.
586	(f) Provides a certification from the dean of the college
587	that he or she has accepted the offer of a full-time faculty
588	appointment to teach at Florida State University.
589	(2) The certificate shall authorize the holder to practice
590	only in conjunction with his or her faculty position at Florida
591	State University and its affiliated clinics that are registered
592	with the Board of Chiropractic Medicine as sites at which
593	holders of chiropractic medicine faculty certificates will be
594	practicing. Such certificates shall automatically expire upon
595	termination of the holder's relationship with the school or
596	after a period of 2 years, whichever occurs first.
597	(3) The holder of a faculty certificate may engage in the
598	practice of chiropractic medicine as permitted by this section.
599	(4) Notwithstanding the provisions of subsection (2), a
600	chiropractic medicine faculty certificate is renewable every 2
601	years by a holder who applies to the Board of Chiropractic
602	Medicine on a form prescribed by the Board of Chiropractic
603	Medicine and who continues to satisfy the requirements set forth
604	in subsection (1).
605	Section 28. Except as otherwise expressly provided, this
606	act shall take effect July 1, 2003, but if it becomes a law
607	after May 1, 2003, sections 13 and 14 of this act shall
608
609	================= T I T L E A M E N D M E N T =================
610	On page 1, line 2,
611	remove: all of said line
612
613	and insert:
614	An act relating to health care; creating s. 430.83, F.S.;
615	providing a popular name; providing definitions; providing
616	legislative findings and intent; creating the Sunshine for
617	Seniors Program to assist low-income seniors with
618	obtaining prescription drugs from manufacturers’
619	pharmaceutical assistance programs; providing
620	implementation and oversight duties of the Department of
621	Elderly Affairs; providing for community partnerships;
622	providing for contracts; requiring annual evaluation
623	reports on the program; specifying that the program is not
624	an entitlement; amending s. 409.9065, F.S.; revising the
625	pharmaceutical expense assistance program for low-income
626	elderly individuals; adding eligibility groups; providing
627	benefits; requiring the Agency for Health Care
628	Administration, in administering the program, to
629	collaborate with both the Department of Elderly Affairs
630	and the Department of Children and Family Services;
631	requiring federal approval of benefits; amending s.
632	430.502, F.S.; requiring the Agency for Health Care
633	Administration and the Department of Health to seek and
634	implement a Medicaid home and community-based waiver for
635	persons with Alzheimer's disease; requiring the
636	development of waiver program standards; providing for
637	consultation with the presiding officers of the
638	Legislature; providing for a contingent future repeal of
639	such waiver program; amending s. 408.036, F.S.; providing
640	an exemption from certificate-of-need requirements for
641	certain open-heart-surgery programs; providing criteria
642	for qualifying for the exemption; requiring the Agency for
643	Health Care Administration to report to the Legislature;
644	providing a continuing appropriation for the Florida
645	Alzheimer’s Center and Research Institute; providing an
646	appropriation for construction of the Florida Alzheimer's
647	Center and Research Institute; creating the James and
648	Esther King Center for Universal Research to Eradicate
649	Disease; providing intent and duties; creating an advisory
650	council; amending s. 215.5602, F.S.; expanding the long-
651	term goals and funding of the Florida Biomedical Research
652	Program to include the cure of specified diseases;
653	creating the Florida Cancer Research Cooperative;
654	providing for a board of directors; providing the
655	cooperative's mission and duties; providing a continuing
656	appropriation for the James and Esther King Center for
657	Universal Research to Eradicate Disease; creating s.
658	1004.383, F.S.; authorizing a chiropractic medicine degree
659	program at Florida State University; creating s. 460.4062,
660	F.S.; authorizing the Department of Health to issue a
661	chiropractic medicine faculty certificate to certain
662	chiropractic medicine faculty; authorizing a fee;
663	providing requirements; providing for renewal and
664	expiration of certificates;